225 related articles for article (PubMed ID: 12876517)
1. [Willingness to prescribe by international non proprietary names: general practitioners attitudes in South East France in 2002].
Verger P; Gourheux JC; Villani P; Desquins B; Bouvenot G; Paraponaris A;
Presse Med; 2003 Jun; 32(22):1022-5. PubMed ID: 12876517
[TBL] [Abstract][Full Text] [Related]
2. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
[TBL] [Abstract][Full Text] [Related]
3. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names.
Paraponaris A; Verger P; Desquins B; Villani P; Bouvenot G; Rochaix L; Gourheux JC; Moatti JP;
Health Policy; 2004 Oct; 70(1):23-32. PubMed ID: 15312707
[TBL] [Abstract][Full Text] [Related]
4. INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice.
De Bruyne F; Ponçon A; Giai J; Dode X; Darmon D; Colin C; Gueyffier F; Letrilliart L
Eur J Clin Pharmacol; 2019 Feb; 75(2):275-283. PubMed ID: 30368571
[TBL] [Abstract][Full Text] [Related]
5. [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].
Fraeyman J; De Winter J; De Loof H; Van Hal G; Beutels P; Remmen R; De Meyer GR
J Pharm Belg; 2013 Jun; (2):18-31. PubMed ID: 23798183
[TBL] [Abstract][Full Text] [Related]
6. Design of a national and regional survey among French general practitioners and method of the first wave of survey dedicated to vaccination.
Le Maréchal M; Collange F; Fressard L; Peretti-Watel P; Sebbah R; Mikol F; Agamaliyev E; Gautier A; Pulcini C; Verger P
Med Mal Infect; 2015 Oct; 45(10):403-10. PubMed ID: 26494319
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
Kersnik J; Peklar J
J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with GPs' knowledge of their patients' socio-economic circumstances: a multilevel analysis.
Casanova L; Ringa V; Bloy G; Falcoff H; Rigal L
Fam Pract; 2015 Dec; 32(6):652-8. PubMed ID: 26311704
[TBL] [Abstract][Full Text] [Related]
9. How public reporting of prescription quality indicators influence prescribing practices? A survey of general practitioners.
Du X; Zhang X; Tang Y; Zhang X; Wang L; Wang X
J Eval Clin Pract; 2015 Oct; 21(5):943-51. PubMed ID: 26202749
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' attitudes and behaviors toward HPV vaccination: A French national survey.
Collange F; Fressard L; Pulcini C; Sebbah R; Peretti-Watel P; Verger P
Vaccine; 2016 Feb; 34(6):762-8. PubMed ID: 26752063
[TBL] [Abstract][Full Text] [Related]
11. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
Chua GN; Hassali MA; Shafie AA; Awaisu A
Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
[TBL] [Abstract][Full Text] [Related]
12. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
[TBL] [Abstract][Full Text] [Related]
13. [Prescription of high dose buprenorphine by general practitioners].
Feroni I; Paraponaris A; Aubisson S; Bouhnik A; Masut A; Ronfle E; Coudert C; Mabriez JC;
Rev Epidemiol Sante Publique; 2004 Dec; 52(6):511-22. PubMed ID: 15741914
[TBL] [Abstract][Full Text] [Related]
14. General practitioners and the National Strategy on Sexual Health and HIV.
Rogstad KE; Henton L
Int J STD AIDS; 2004 Mar; 15(3):169-72. PubMed ID: 15038862
[TBL] [Abstract][Full Text] [Related]
15. Attitudes and barriers to involvement in palliative care by Australian urban general practitioners.
Rhee JJ; Zwar N; Vagholkar S; Dennis S; Broadbent AM; Mitchell G
J Palliat Med; 2008 Sep; 11(7):980-5. PubMed ID: 18788958
[TBL] [Abstract][Full Text] [Related]
16. General practitioners and national health insurance--results of a national survey.
Blecher MS; Jacobs T; McIntyre D
S Afr Med J; 1999 May; 89(5):534-40. PubMed ID: 10416457
[TBL] [Abstract][Full Text] [Related]
17. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
[TBL] [Abstract][Full Text] [Related]
18. Willingness to offer chlamydia testing in general practice in New South Wales.
Khan A; Hussain R; Plummer D; Minichiello V
Aust N Z J Public Health; 2006 Jun; 30(3):226-30. PubMed ID: 16800198
[TBL] [Abstract][Full Text] [Related]
19. General practitioners on dementia: tasks, practices and obstacles.
van Hout H; Vernooij-Dassen M; Bakker K; Blom M; Grol R
Patient Educ Couns; 2000 Feb; 39(2-3):219-25. PubMed ID: 11040721
[TBL] [Abstract][Full Text] [Related]
20. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
